485 Results (Page 11 of 20)
China Markets Research Reports
China Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the China Liver Disease Therapeutics market will reach a value of $3.23 Bn from $1.85 Bn in 2022, growing at a CAGR of 7.2% during 2022-30. Liver Disease Therapeutics in China is dominated by a few domestic pharmaceutical companies such as Simcere, Beijing, and Fosun Pharma. The Liver Disease Therapeutics market in China is segmented into different types of disease and different therapy types. Some of the major factors affecting the China Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
China Healthcare Diagnostics Market Analysis
This report presents a strategic analysis of the China Healthcare Diagnostics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the China Healthcare Diagnostics Market, offering unmatched value, accuracy, and expert insights.
China ENT Devices Market Analysis
China's ENT Devices Market is projected to grow from $1.86 Bn in 2022 to $3.26 Bn by 2030, registering a CAGR of 7% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the China ENT devices market include Beijing Konted Medical Technology, Xuzhou Hengda Electronic, and Shenzhen.
China Depression Therapeutics Market Analysis
China's depression therapeutics market is expected to witness growth from $812 Mn in 2022 to $1,364 Mn in 2030 with a CAGR of 6.7% for the forecasted year 2022-30. The rising prevalence of mental health disorders especially depression in China and the consequent increased demand for therapeutic options for treatment in China are responsible for the growth of the market. The China depression therapeutics market is segmented by drug type, therapies, indication, and end users. Walvax Biotechnology, Shanghai Pharmaceuticals, and AstraZeneca are the major players in the China depression therapeutics market.
China Coronary Stents Market Analysis
China's Coronary Stents Market is expected to witness growth from $908 Mn in 2022 to $1475 Mn in 2030 with a CAGR of 6.25% for the forecasted year 2022-30. In China, procedures involving coronary stents are completely minimally invasive, which means the patient has less pain and requires smaller incisions. The need for coronary stent surgeries has increased as a result in the country. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include Lepu Medical Technology, MicroPort, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific and Philips Healthcare.
China Contraceptive Devices Market Analysis
China's Contraceptive Devices Market is expected to witness growth from $1037 Mn in 2022 to $2143 Mn in 2030 with a CAGR of 9.50% for the forecasted year 2022-30. In China, there is an increasing demand for contraceptive methods due to a growing understanding of the advantages of family planning. This is influenced by things like rising urbanization, women's emancipation, and government programs to slow population increase. The market is segmented by type and by gender. Some key players in this market include Suzhou Medical Supplies, Xian Janssen Pharmaceutical, Mylan Laboratories, Shenzhen Huikang Medical Apparatus, CooperSurgical, Pfizer, Pregna International, and Teva Pharmaceutical.
China Anti Aging Therapeutics Market Analysis
China's anti-aging therapeutics market is projected to grow from $49 Mn in 2022 to $183 Mn in 2030 with a CAGR of 18.03% for the year 2022-30. As China has the fastest-growing elderly population in the world, the market is projected to expand during the forecast period. Further, the concerns over the appearance of social media among the young Chinese population are also responsible for the growth of the market. The China anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Some of the top players in the market include Harbour BioMed, Hua Medicine, and Rejuvenate Bio.
China Over The Counter (OTC) Pharmaceuticals Market Analysis
China's over-the-counter (OTC) pharmaceuticals market size was valued at $11053.3 Mn in 2022 and is estimated to expand at a CAGR of 7.04% from 2022 to 2030 and will reach $19048.4 Mn in 2030. OTC are non-prescription medications and are a vital component of the healthcare system, offering consumers accessible solutions for a wide range of common health issues. The market is segmented by product type and distribution channel. The key market players are Johnson and Johnson Services Inc (USA), Bayer AG (Germany), Novartis AG (Switzerland) and others.
China Anemia Drugs Market Analysis
China's Anemia drugs market was valued at 1.28 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 10.4% from 2022 to 2030 and will reach $2.83 Bn in 2030. One of the main reasons propelling the growth of this market is an increase in income and the aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Roche, Novartis, Sanofi, Shanghai Pharmaceuticals, Sinopharm Group, Jiangsu Hengrui Medicine, and Guangzhou Baiyunshan Pharmaceutical among others.
China Healthcare Financial Analytics Market Analysis
The China Healthcare Financial Analytics market size was valued at $xx Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 8.3% from 2022 to 2030 and will reach $xx Mn in 2030. The market is segmented by type, component, and deployment. China’s Healthcare Financial Analytics market will grow as the adoption of technology in the healthcare industry is increasing in China, which is driving demand for healthcare financial analytics solutions. The key market players are Yitu Healthcare, Infervision, United Imaging, Wision AI, Yidu Cloud, Ping An Healthcare and Technology Company, BGI Genomics, and others.
China Women Health Diagnostic Market Analysis
This report presents a strategic analysis of the China Women's Health Diagnostic Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the China Women's Health Diagnostic Market, offering unmatched value, accuracy, and expert insights.
China Patient Engagement Solutions Market Analysis
China's patient engagement solutions market is projected to grow from $1.37 Bn in 2022 to $3.82 Bn by 2030, registering a CAGR of 13.7% during the forecast period of 2022-30. The main factors driving the growth would be the aging population, chronic disease management, increasing healthcare spending, and government support. The market is segmented by component, delivery mode, application, therapeutic area, functionality, and end-user. Some major players include JD Health, Vecoton, Ping An Good Doctor, Oracle, and Lincor.
China Neurology Devices Market Analysis
China's Neurology Device Market size is at around $1.01 Bn in 2022 and is projected to reach $2.07 Bn in 2030, exhibiting a CAGR of 9.3% during the forecast period (2022-2030). China is a leading manufacturer and simultaneous consumer of neuro devices attributed to its dominance in research and manufacturing excellence by major players like Mindray Medical International, Medtronic, JinkoSolar Holding, and Lepu Medical Technology. This report by Insights10 is segmented by product type like neurostimulation, interventional neurology, neurosurgery devices, and neuro-endoscopes, and by the end user.
China Acne Therapeutics Market Analysis
China's acne therapeutics market is expected to witness growth from $806 Mn in 2022 to $1,515 Mn in 2030 with a CAGR of 8.2% for the forecasted year 2022-30. The main market drivers of this market are growing sedentary lifestyles and demand for minimally invasive cosmetic treatment in China. The market is segmented by treatment, route of administration, age group, and distribution channel. Botanix Pharmaceuticals, Galderma, and Bausch are some of the key players in the China acne therapeutics market.
China 3D Printing Medical Devices Market Analysis
China's 3D printing medical devices market size was valued at $239 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 17.8% from 2022 to 2030 and will reach $ 885 Mn in 2030. The market is segmented by component, application, technology, and end user. The China 3D Printing Medical Devices market will grow as the 3D printing technology allows for the customization of medical devices, which is becoming increasingly important in the healthcare industry. The key market players are Tiertime, Beijing Long Yuan Automated Fabrication System Co., Ltd., Shining 3D, and others.
China 3D Imaging Market Analysis
China's 3D imaging market is projected to grow from $ 2.44 Bn in 2022 to $ 9.18 Bn by 2030, registering a CAGR of 18% during the forecast period of 2022-30. The market will be driven by rising healthcare spending and rising chronic illness rates, driving up demand for better medical imaging technologies. The market is segmented by product, application, end-user, and portability. Some of the major players include Canon Medical Systems Corporation, GE Healthcare, Mindray Medical International Limited & Fussen Technology.
China Multiple Myeloma Therapeutics Market Analysis
The China Multiple Myeloma Therapeutics Market was valued at $670 Mn in 2022 and is estimated to expand at a CAGR of 7.5% from 2022 to 2030 and will reach $1069 Mn in 2030. One of the main reasons propelling the growth of this Market is Rising disposable income, aging population. The Market is segmented by type, drug and distribution channel. Some key players in this Market are BeiGene, Innovent Biologics, Simcere, Hengrui Medicine, CSPC Pharmaceutical and others.
China Acromegaly Therapeutics Market Analysis
China Acromegaly Therapeutics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023-30. The prevalence and incidence of acromegaly and pituitary tumours are rising, as is global awareness of the disease. Technological advances in the development of new acromegaly medications are also key contributors to the market's growth. The high prevalence of hormonal problems, evolving lifestyles, and rising genetic disease incidence are all anticipated to fuel market expansion.Some of the key players in the global acromegaly therapeutics Market include Roche, Sanofi, GSK, Pfizer INC., Ipsen, Chiasma Inc, Validus pharmaceuticals LLC., Novartis AG, Amryt, Recordati, Sun Pharma, Crinetics Pharmaceuticals, Camurus, Ionis Pharmaceuticals , and Others.
China Adrenoleukodystrophy (ALD) Therapeutics Market Analysis
China Adrenoleukodystrophy (ALD) Drugs Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023-30. Drivers of acromegaly market are increasing cases of the disorder which in turn increased awareness and government focus motivated financial support to R&D. Poxel SA, Bluebird Bio Inc.,Viking Technologies, Minoryx Therapeutics sl., Apteeus SAS, Ashvattha Therapeutics LLC, NeuroVia Company, Autobahn Therapeutics Inc., Aldagen Inc., Celularity Inc., Imstem Biotechnology Inc., MedDay SA, and Orpheris Inc. are major competitors in the China Adrenoleukodystrophy (ALD) drugs market.
China Alport Syndrome Therapeutics Market Analysis
China during the forecast period of 2023-30, the Alport Syndrome therapeutics market is anticipated to increase from $xx Mn in 2023 to $xx Mn by 2030, recording a CAGR of xx percent. Almost always affecting the kidney, Alport syndrome is a multisystem condition that also usually affects the inner ear and the eye. A variety of symptoms that normally start in childhood or adolescence and may get worse over time can be present. Invitae Corporation, Hoffmann-La Roche Ltd., Centogene N.V., and Eurofins Discovery are a few of the leading companies in the worldwide Alport syndrome market.
China Anal Fistula Therapeutics Market Analysis
China During the forecast period of 2023?2030, the Anal Fistula Therapeutics Market is anticipated to increase from $xx Mn in 2023 to $xx Mn by 2030, recording a CAGR of xx percent. A rare intestinal ailment that typically appears following an acute perianal abscess and is defined by improper connection between the lower rectum and the perianal skin. The market is expanding more quickly thanks to technological advancements in anal fistula therapy. The development of novel surgical treatment options and the explosive growth of the medical tourism business have contributed to the sector's segment expansion. The leading companies profiled in the market research study on anal fistula treatment include Becton, Medtronic, Dickinson and Company, Gem Srl, Biolitec AG, BD, Johnson & Johnson Services, Inc., Mylan N.V., Takeda Pharmaceutical Company Limited, W. L. Gore & Associates, Cook, KARL STORZ SE & Co. KG, Novartis AG, Boehringer Ingelheim International GmbH, Pfizer.
China Angelman Syndrome Therapeutics Market Analysis
China During the forecast period of 2023?2030, The Angelman Syndrome Therapeutics Market is anticipated to increase from $xx Mn in 2023 to $xx Mn by 2030, recording a CAGR of xx percent. An uncommon inherited neuro-developmental condition called Angelman Syndrome is marked by a severe developmental delay, sleep issues, jerky movements, and a lot of laughter. As the illness is more common, there are more government measures to manage it. This has also helped with research and development for condition treatment. These factors collectively represent the Angelman Syndrome Therapeutics Market's driving forces. Boston Children's Hospital, the Angelman Syndrome Foundation, Rady Children's Hospital in San Diego, General Hospital Corporation, Cincinnati Children's Hospital Medical Center, and others are major competitors in the market for treating Angelman syndrome.
China Ankylosing Spondylitis Therapeutics Market Analysis
China Ankylosing Spondylitis Drugs market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023-30. Ankylosing spondylitis is a kind of arthritis that affects connective tissues. The sacroiliac joints, which connect the spine to the pelvis, become inflamed, but in extreme situations, the spine's bones might fuse together and become very inflexible. A rough estimate of 1.1 Mn Americans, or one out of every 200 adults, are impacted. Abbvie, Amgen, Eli Lilly, Janssen, Merck, Pfizer, Novartis, UCB, and many other leading companies are active in the ankylosing spondylitis global market. To increase their market share, these businesses engage in strategic alliances and acquisitions in addition to concentrating on research and development to bring novel therapies to market.
China Uveitis Therapeutics Market Analysis
China Uveitis therapeutics market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. Uveitis is an inflammation of the uvea, which is the middle layer of the tissue that surrounds the eye and is made up of the iris, ciliary body, and choroid. The most typical extra-articular Spondyloarthritis symptom is uveitis (SpA) Increased healthcare financing, together with the development of drugs with improved efficacy and fewer side effects, has benefited technological advancements in the field, which together are serving as a potential driver of the uveitis therapeutic market. Several well-known companies involved in the development and marketing of uveitis medicines include Novartis AG, Bausch Health Companies Inc., Santen Pharmaceutical Co., Ltd., Sun Pharmaceutical Industries Ltd., Johnson & Johnson, AbbVie Inc., and Allergan (now a division of AbbVie).
China Anthrax Therapeutics Market Analysis
China Anthrax therapeutics market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. Bacillus anthracis is the bacteria that causes anthrax (B. anthracis). The market for anthrax therapeutics is fueled by factors such the increased prevalence of bacterial infections, rising research funding, the development of innovative medicines for treating anthrax, and pipeline goods, which increase demand and stimulate market expansion. The current rise in healthcare spending in both developed and developing nations is anticipated to give manufacturers a competitive edge in the development of novel and ground-breaking products. Global industries in the Anthrax therapeutics market are Aristo Pharmaceuticals Private Limited, Indoco Remedies Ltd., Lupin, Deinove, Bayer AG, Pfizer Inc., Emergent, Soligenix, Zydus Group, Sanofi, Alembic Pharmaceuticals, Emergent, Sanofi, Porton Biopharma, Lupin, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd and many more